Google快讯 - lung cancer

	lung cancer 实时更新 ⋅ 2024年4月30日
	新闻
	Glecirasib Shows Promising Efficacy in KRAS G12C+ Advanced NSCLC - Cancer Network Cancer Network Amivantamab/chemotherapy has been recommended for approval by the CHMP in advanced non–small cell lung cancer with EGFR exon 20 insertion mutations. 标记为不相关
	EPA rule bans toxic chemical that's commonly used as paint stripper but known to cause liver cancer WWNY Long-term health ... 标记为不相关
查看更多结果 | 修改此快讯

您收到此电子邮件是因为您订阅了Google快讯。 退订 | 查看您所有的快讯

以RSS Feed的形式接收此快讯

发送反馈